Dr Reddy's launches Rapamune's generic version in the US
30 October 2014 | News | By BioSpectrum Bureau
Dr Reddy's launches Rapamune's generic version in the US
(Photo Courtesy: www.nordiclifescience.org)
The generic drug has received approval nod from the United States Food and Drug Administration (USFDA).
The Rapamune tablets brand had US sales of approximately $206 million MAT for the most recent twelve months ending in August 2014, according to IMS Health.
Dr Reddy's Sirolimus tablets are available in 1mg and 2mg in bottle counts of 100.
